[1]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2007/31265,2007,A2Locationinpatent:Page/Pagecolumn39
[2]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-WO2006/59234,2006,A2Locationinpatent:Page/Pagecolumn63
[1]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2007/31265,2007,A2Locationinpatent:Page/Pagecolumn40
[2]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-WO2006/59234,2006,A2Locationinpatent:Page/Pagecolumn63
[1]Bold,Guido;Schnell,Christian;Furet,Pascal;McSheehy,Paul;Brüggen,Josef;Mestan,Jürgen;Manley,PaulW.;Drückes,Peter;Burglin,Marion;Dürler,Ursula;Loretan,Jacqueline;Reuter,Robert;Wartmann,Markus;Theuer,Andreas;Bauer-Probst,Beatrice;Martiny-Baron,Georg;Allegrini,Peter;Goepfert,Arnaud;Wood,Jeanette;Littlewood-Evans,Amanda[JournalofMedicinalChemistry,2016,vol.59,#1,p.132-146]
[1]Bold,Guido;Schnell,Christian;Furet,Pascal;McSheehy,Paul;Brüggen,Josef;Mestan,Jürgen;Manley,PaulW.;Drückes,Peter;Burglin,Marion;Dürler,Ursula;Loretan,Jacqueline;Reuter,Robert;Wartmann,Markus;Theuer,Andreas;Bauer-Probst,Beatrice;Martiny-Baron,Georg;Allegrini,Peter;Goepfert,Arnaud;Wood,Jeanette;Littlewood-Evans,Amanda[JournalofMedicinalChemistry,2016,vol.59,#1,p.132-146]
[1]JournalofMedicinalChemistry,2016,vol.59,p.132-146
Title: Bold G, et al. A Novel Potent Oral Series of VEGFR2 Inhibitors Abrogate Tumor Growth by Inhibiting Angiogenesis. J Med Chem. 2016 Jan 14;59(1):132-46.